Matthew Palmer, DO
Obstetrics & Gynecology · Crystal, MNNPI 1437354099
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $86,915 of the $138,282 with a category attached, or 62.9%. 22 manufacturers reported payments, led by AbbVie at 58.1% of the total. Reporting peaked in 2019 at $66,869 and has fallen 86.2% since, to $9,257 in 2025. Among obstetrics & gynecology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $430.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$80K
- Intuitive Surgical$32K
- Boston Scientific$12K
- Axonics, Inc.$4K
- Myovant Sciences Inc.$3K
- Medtronic$2K
- plus $4K from 16 others
Across 2 payments — averaging $531.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
What the payments were for
- Consulting fees$7,7746%
- Speaking & faculty fees$86,91563%
- Travel & lodging$11,6298%
- Food & beverage$9,7987%
- Education$22,12116%
- Gifts$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 128 | $80,352 |
| Intuitive Surgical | 42 | $32,233 |
| Boston Scientific | 35 | $12,429 |
| Axonics, Inc. | 48 | $4,466 |
| Myovant Sciences Inc. | 6 | $2,992 |
| Medtronic(2 entities) | 21 | $1,551 |
| Sumitomo Pharma America, Inc. | 3 | $995 |
| Momentis Surgical Inc. | 2 | $971 |
| Covidien LP | 1 | $488 |
| Caldera Medical, Inc | 5 | $459 |
| Minerva Surgical, Inc | 8 | $430 |
| Hologic Sales And Service, LLC | 5 | $338 |
| Asensus Surgical, Inc. | 1 | $166 |
| Acessa Health Inc. | 1 | $123 |
| Coopersurgical, Inc. | 5 | $97 |
| Astellas Pharma US Inc | 4 | $65 |
| Baxter Healthcare | 1 | $28 |
| Exact Sciences | 1 | $22 |
| Coloplast | 1 | $22 |
| Pfizer | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $18 |
| Organon | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$69,431
- Da Vinci Surgical System$29,753
- ORIAHNN$11,527
- MYFEMBREE$3,920
- Advantage System$3,040
- GENERAL FEMALE SUI$2,550
- Axonics$2,436
- DA VINCI SP$2,000
- ADVANTAGE FIT$1,969
- GENERAL - THERAPIES$1,784
- Bulkamid$1,581
- Humira$1,275
- SOLYX$1,143
- Anovo Surgical System$944
- Axonics r-SNM System$909
- Solyx SIS System$760
- INTERSTIM$412
- Desara$369
- GENERAL PELVIC ORGAN PROLAPSE$358
- UPSYLON$356
How this compares
$138,282 in reported general payments places this provider in the 95th percentile of 615 obstetrics & gynecology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrilissaElagolix Sodium | 11 | $12,961 |
| GemtesaVibegron | 15 | $10,547 |
| Estradiol | 19 | $713 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $60 |
| Oxycodone Hcl | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieOrilissa | $80,352 | $12,96111 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $995 | $10,54715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 615 obstetrics & gynecology providers in Minnesota.
Other obstetrics & gynecology in Crystal
- Eric EnglishLake Elmo$228K
- Eugen CampianRed Wing$137K
- Kirk ShibleyEdina$130K
- Christy Boraas AlslebenMinneapolis$44K
- Jani JensenRochester$42K
- Rachel CadyCrosby$29K
- Regan TheilerRochester$20K
- Eric HeegaardMinneapolis$18K
- Ashleigh SwearingenNew Ulm$17K
- Scott BarnacleMinneapolis$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.